These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8346344)

  • 1. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
    Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
    Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
    Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
    Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
    Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
    Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
    Corvò R; Sanguineti G; Vitale V; Bacigalupo A; Margarino G; Benasso M; Numico GM; Giaretti W
    Rays; 1997; 22(1 Suppl):69-72. PubMed ID: 9250019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
    J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accelerated radiotherapy with the concomitant-boost technic in patients with squamous cell carcinoma of the head and neck].
    Sanguineti G; Corvò R; Frascio F; Vitale V
    Radiol Med; 1994 Nov; 88(5):650-6. PubMed ID: 7824783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas.
    Corvò R; Giaretti W; Geido E; Sanguineti G; Orecchia R; Scala M; Garaventa G; Mora E; Vitale V
    Int J Cancer; 1996 Oct; 68(2):151-5. PubMed ID: 8900419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S; Cvetkovska E; Westin T; Young C
    Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
    Mariya Y; Aoki M; Tarusawa N; Takekawa S; Kaimori M; Abe Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):976-8. PubMed ID: 8371947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The predictability of the radiotherapy response in epidermoid tumors of the head and neck. A review of the literature and mathematical models for choosing the fractionated doses].
    Corvò R; Scarpati D; Sanguineti G; Vitale V
    Radiol Med; 1990 May; 79(5):520-9. PubMed ID: 2193325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.